Genprex (GNPX) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($2.0 million vs $1.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNPX | REVB |
|---|---|---|
| Share price | $1.45 | $3.50 |
| Market cap | $1.94M | $1.99M |
| 1-day change | -13.17% | -5.15% |
| P/E ratio (TTM) | 0.01 | — |
| EPS (TTM) | $98.47 | $-99.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-16.23M | $-8.91M |
| 52-week high | $80.96 | $40.60 |
| 52-week low | $1.45 | $3.08 |
| Distance from 52-week high | -98.21% | -91.38% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +407.14% |
| Average volume | 168.88K | 12.49K |
| Shares outstanding | 1.33M | 569.06K |
| Employees | 13 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
GNPX vs REVB FAQ
Which is bigger, Genprex or Revelation Biosciences?
Revelation Biosciences (REVB) is larger, with a market capitalization of $1.99M compared with $1.94M for Genprex (GNPX).
Are Genprex and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.